Drug
C Opevesostat
C Opevesostat: highest development phase Phase 1, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| [¹⁴C]Opevesostat NCT06566989 | Phase 1 | Metastatic Prostate Cancer |
Latest
No recent events.
Follow C Opevesostat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.